Invega Sustenna 150 mg

Invega Sustenna 150 mg is an extended-release suspension of paliperidone palmitate for intramuscular use. It is designed to provide long-lasting relief for certain mental health conditions. This medication is manufactured by Janssen Inc. in Canada.

Invega Sustenna 150 mg is primarily used for the treatment of schizophrenia in adults. It works by helping to restore the balance of certain natural substances in the brain. This medication is administered via intramuscular injection and is designed to provide extended relief, reducing the frequency of dosing. Patients often wonder, 'What is Invega Sustenna used for?' and the answer is that it is typically prescribed for managing symptoms of schizophrenia.

Common effects of Invega Sustenna 150 mg may include injection site reactions, weight gain, and drowsiness. Some users may also experience restlessness or dizziness. These effects can vary from person to person and are not exhaustive. It is important to consult with a healthcare provider for personalized information.

Invega Sustenna 150 mg should be handled with care and administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before starting this medication. Pregnant or breastfeeding women should discuss the risks and benefits with their healthcare provider. Always follow the prescribed dosage and administration instructions.

Invega Sustenna 150 mg may interact with other medications, including those that affect the central nervous system. Alcohol and certain supplements can also interact with this medication. It is crucial to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. Always consult with a healthcare professional for personalized advice.